TrialMultiple sclerosis (Houndmills, Basingstoke, England)2022
Effectiveness and safety of cladribine in MS: Real-world experience from two tertiary centres.
Steffen Pfeuffer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this papercites it